- Home
- AMWL vs DERM Comparison
AMWL vs DERM Comparison
Compare AMWL & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMWL
- DERM
- Stock Information
- Founded
- AMWL 2006
- DERM 2014
- Country
- AMWL United States
- DERM United States
- Employees
- AMWL N/A
- DERM N/A
- Industry
- AMWL Retail: Computer Software & Peripheral Equipment
- DERM Biotechnology: Pharmaceutical Preparations
- Sector
- AMWL Technology
- DERM Health Care
- Exchange
- AMWL Nasdaq
- DERM Nasdaq
- Market Cap
- AMWL 121.9M
- DERM 140.0M
- IPO Year
- AMWL 2020
- DERM 2021
- Fundamental
- Price
- AMWL $6.98
- DERM $6.25
- Analyst Decision
- AMWL Hold
- DERM Strong Buy
- Analyst Count
- AMWL 6
- DERM 2
- Target Price
- AMWL $11.00
- DERM $10.00
- AVG Volume (30 Days)
- AMWL 46.6K
- DERM 103.6K
- Earning Date
- AMWL 05-01-2025
- DERM 05-12-2025
- Dividend Yield
- AMWL N/A
- DERM N/A
- EPS Growth
- AMWL N/A
- DERM N/A
- EPS
- AMWL N/A
- DERM N/A
- Revenue
- AMWL $254,364,000.00
- DERM $56,134,000.00
- Revenue This Year
- AMWL $2.28
- DERM $29.83
- Revenue Next Year
- AMWL $10.06
- DERM $54.88
- P/E Ratio
- AMWL N/A
- DERM N/A
- Revenue Growth
- AMWL N/A
- DERM N/A
- 52 Week Low
- AMWL $5.00
- DERM $3.20
- 52 Week High
- AMWL $12.95
- DERM $7.29
- Technical
- Relative Strength Index (RSI)
- AMWL 39.26
- DERM 53.65
- Support Level
- AMWL $6.86
- DERM $5.98
- Resistance Level
- AMWL $7.55
- DERM $6.40
- Average True Range (ATR)
- AMWL 0.56
- DERM 0.62
- MACD
- AMWL 0.09
- DERM -0.06
- Stochastic Oscillator
- AMWL 49.30
- DERM 36.97
About AMWL American Well Corporation
American Well Corp is a telehealth company enabling digital delivery of care for its customers. Its platform, Amwell, digital care delivery solution that equips health systems, health plans, government, and innovator clients with the tools to enable new models of care for their patients and members enabling care delivery across the full healthcare continuum - from primary and urgent care in the home to high acuity specialty consults, such as telestroke and telepsychiatry, in the hospital. It provides both on-demand and scheduled consultations. Its Health Plan Programs include Virtual Primary Care, Musculoskeletal Care, Dermatology Care, and Chronic Care among others.
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.